| scholarly article | Q13442814 |
| P2093 | author name string | H Soran | |
| H M Ziglam | |||
| M N Choudhry | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| Clostridium difficile | Q310543 | ||
| P304 | page(s) | 445-448 | |
| P577 | publication date | 2008-04-14 | |
| P1433 | published in | QJM: An International Journal of Medicine | Q7265477 |
| P1476 | title | Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease | |
| P478 | volume | 101 |
| Q34400622 | Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias |
| Q38865456 | Acid-Suppressive Therapy and Risk of Infections: Pros and Cons |
| Q89622068 | Administration of aspirin tablets using a novel gel-based swallowing aid: an open-label randomised controlled cross-over trial |
| Q36125513 | Adverse drug reactions in special populations - the elderly |
| Q36592533 | An automated tool for detecting medication overuse based on the electronic health records |
| Q38873800 | Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis |
| Q38811584 | Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center |
| Q34213711 | Clostridium difficileinfection and inflammatory bowel disease: Understanding the evolving relationship |
| Q39307398 | Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis |
| Q35570502 | Developing a formal representation for medication appropriateness criteria |
| Q51142763 | Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease |
| Q46105665 | Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis |
| Q35619442 | Effect of fiber supplementation on the microbiota in critically ill patients |
| Q92417285 | Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study |
| Q58557244 | Evaluation of Prescribing Appropriateness and Initiatives to Improve Prescribing of Proton Pump Inhibitors at Vancouver General Hospital |
| Q36020653 | Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis |
| Q39182584 | Inhibition of lysosomal enzyme activities by proton pump inhibitors |
| Q43178513 | Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications |
| Q36570868 | Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma |
| Q36195428 | National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals |
| Q37639328 | Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction |
| Q47984107 | Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database |
| Q33795093 | Potentially inappropriate prescribing and cost outcomes for older people: a national population study |
| Q37972019 | Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis |
| Q40799000 | Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. |
| Q34007345 | Proton pump inhibitor discontinuation in long-term care |
| Q35072261 | Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all? |
| Q42969618 | Proton pump inhibitor-induced hypomagnesemia: A new challenge |
| Q48160016 | Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study |
| Q34186827 | Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies |
| Q36064989 | Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study |
| Q42695192 | Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis |
| Q33621128 | Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies |
| Q55230586 | Review of Proton Pump Inhibitor Overuse in the US Veteran Population. |
| Q38004673 | Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis |
| Q40135306 | Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans |
| Q38404870 | The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study |
| Q37709906 | The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus |
| Q42937186 | Tube feeding, the microbiota, and Clostridium difficile infection |
| Q36234202 | Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents |
Search more.